Posters

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29

Sunday, September 27

3:00 PM - 4:00 PM ET

2217 - Machine Learning-Based Clinico-Radiomic Model for Predicting Brain Metastasis Velocity after Stereotactic Radiosurgery: A Multi-Institutional Validation Study
Speaker: Shieh, Cheng-Shien, MD - Taipei Medical University Hospital, Taipei 10449, Taiwan
3:00 PM - 4:00 PM ET

2218 - The Effect of Non-Enhancing Peri-Tumoral Hemorrhage on Local Control for Melanoma Brain Metastases Treated with Stereotactic Radiosurgery
Speaker: Shohayeb, Muhammad, MD, MBChB - UPMC Cancer Center, Pittsburgh, PA
3:00 PM - 4:00 PM ET

2219 - Tonotopic Cochlear Dose as a Predictor of Hearing Loss after Radiosurgery
Speaker: Shrivastava, Shrishti, BS - Rush Medical College of Rush University, Chicago, IL
3:00 PM - 4:00 PM ET

2220 - Neoadjuvant Radiotherapy Combined with Lenvatinib and Sintilimab in Patients with Resectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: An Open-Label, Single-Arm, Multicenter, Prospective Phase I Clinical Trial
Speaker: Shu, Bin - Hepatopancereatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing
3:00 PM - 4:00 PM ET

2221 - External Beam Radiotherapy for Gastroenteropancreatic Neuroendocrine Neoplasms: Long-Term Local Control, Survival and Toxicity
Speaker: Tang, Yuan, MD - Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, Beijing
3:00 PM - 4:00 PM ET

2222 - Treatment Mode and Prognostic Factors of Radiotherapy-Related Esophageal Fistula in Patients with Eesophageal Squamous Cell Carcinoma: A Retrospective Cohort Study
Speaker: Si, Hanyu, MD, MB - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, Hebei
3:00 PM - 4:00 PM ET

2223 - Association of Pancreatic Cancer Resection and Post-recurrence Disease Course
Speaker: Silberstein, Alice, MD - Harvard Radiation Oncology Program, Boston, MA
3:00 PM - 4:00 PM ET

2224 - The Pediatric AVM Experience
Speaker: Simpson, Andrew, MD - UAB Radiation Oncology, Birmingham, AL
3:00 PM - 4:00 PM ET

2225 - Locoregional Treatment Outcomes of Hepatocellular Carcinoma Defined by Large Tumor Size or Macrovascular Invasion with Yttrium-90 Radioembolization and Stereotactic Body Radiation Therapy
Speaker: Singh, Abhiram - University of California Los Angeles, Los Angeles, CA
3:00 PM - 4:00 PM ET

2227 - Outcomes Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Single Institution Experience
Speaker: Skipper, Andrew, MD - Duke University Health System, Durham, NC
3:00 PM - 4:00 PM ET

2228 - Multi-Institutional Analysis of Dose and Factors Associated with All Cause Morbidity after Stereotactic Radiotherapy for Intact Melanoma Brain Metastases
Speaker: Snyder, Owen, BA - University of Cincinnati College of Medicine, Cincinnati, OH
3:00 PM - 4:00 PM ET

2229 - Stereotactic Body Radiation Therapy for the Treatment of Spinal Chordomas - A Single Institutional Retrospective Review
Speaker: Song, Grace, BA - Cleveland Clinic Foundation, Cleveland, OH